Characteristics of “super responders” and “super nonresponders” to first biologic monotherapy for psoriasis: a nested case-control study
BJD, 2023.
Kayleigh J. Mason, Oras A. Alabas, Nick Dand, Richard B. Warren, Nick J. Reynolds, Jonathan N.W.N. Barker, Zenas Z. N. Yiu, Catherine H. Smith, Christopher E.M. Griffiths, the BADBIR Study Group.
Read publication: BJD
Related
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000...
Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR
Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic ...
0 Comments